SACRAMENTO, Calif., Jan. 8, 2013 (GLOBE NEWSWIRE) -- Aerojet, a GenCorp (NYSE:GY) company, announced today that the Missile Defense Agency (MDA) has awarded the company a multi-million dollar contract to develop advanced Solid Divert and Attitude Control System (SDACS) technologies for the Standard Missile-3 (SM-3) Block IIB interceptor.
This development contract will advance SDACS technology to increase flight duration, mission flexibility and overall performance required for the SM-3 IIB missile, ultimately reducing technical risk for the future SM-3 IIB Missile Product Development Phase.
"This SDACS Risk Reduction Technology Program is a key element of MDA's strategy for early demonstration of shipboard-compatible technologies for the SM-3 IIB missile that can be based on land or at sea," said Vice President of Advanced Programs, Marshall Cousineau. "Aerojet will build upon the successes of our flight-demonstrated SM-3 Block IB TDACS and development underway on our SM-3 Block IIA TDACS to provide MDA with an efficient program that will extend the state-of-the-art technology for the Block IIB mission."
The SM-3 Block IIB missile is a key component of Phase IV of the president's Phased Adaptive Approach, which focuses on protecting the U.S. homeland from first generation ICBMs as well as U.S. assets and allies in Europe from regional threats.
Aerojet is a world-recognized aerospace and defense leader providing propulsion and energetics to the space, missile defense, strategic, tactical missile and armaments areas in support of domestic and international markets. GenCorp is a leading technology-based manufacturer of aerospace and defense products and systems with a real estate segment that includes activities related to the entitlement, sale, and leasing of the company's excess real estate assets. Additional information about Aerojet and GenCorp can be obtained by visiting the companies' websites at http://www.Aerojet.com and http://www.GenCorp.com.
The Aerojet logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12048
Forward Looking Statement:
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time to time in GenCorp's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine GenCorp's future results are beyond the ability of GenCorp to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. GenCorp undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.